Pine bark extract has been used in folk medicine all around the world. It has potent antioxidants and compounds that help dilate blood vessels. Pine bark extract is made from the bark of a European coastal pine tree Landes or maritime pine. The scientific name is Pinus maritima. One such product is patented by a French researcher under the name Pycnogenol. In addition to the this brand, there are several other pine bark extract supplements that are sold over the counter (ex. trademarked products Flavangenol, Enzogenol, Oligopen) and many generics, and each of them is slightly or moderately different in their composition due to various factors including the manufacturing and extraction processes. It is difficult to predict or know for certain which are more effective for various medical conditions. I am not aware of any comparison studies.
Pine bark extract, 30 mg per each pill
Pycnogenol is a natural product made from the bark of the European coastal
pine, Pinus maritima. It is rich in
proanthocyanidins, a special
class of water-soluble antioxidant flavonoids, which are excellent free
radical scavengers.
Pine Bark Extract supplement 100 mg per capsule
Pycnogenol versus generic pine bark extract
Each raw material supplier that makes PBE does so using different bark material
and extraction process. It is very, very difficult to know which company's
product will be more effective for various medical conditions or as an
antioxidant. The company that makes Pycnogenol has spent a lot of money
developing their own version and has done a lot of effort with research over
many years. They should be commended for this. However, it is possible that a
much less expensive extract could be just as effective.
Pine bark extract for
menopause symptoms
Dr. Han-Ming Yang of Ham-Ming Hospital in Taiwan have found an extract of
pine-tree bark -- under the brand-name Pycnogenol -- reduced menopause symptoms
such as fatigue, headache, and vaginal dryness when given over a period of
several months. Pine bark extract may improve blood
flow by enhancing blood vessel dilation. The dosage of pine bark extract was 100
mg twice a day.
The Pycnogenol capsules were provided by the product manufacturer,
Switzerland-based Horphag Research. Blood tests indicated improvement in
antioxidant levels. Scandinavian Journal of Obstetrics and Gynecology, 2007.
Hypertension
Pycnogenol, French maritime pine bark extract,
improves endothelial function of hypertensive patients.
Life Sci. 2004.
A placebo-controlled, double-blind, parallel group study was performed
with 58 patients to investigate effects of French maritime pine bark
extract, Pycnogenol, on patients with hypertension. Supplementation of the
patients with 100 mg pine bark extract
over a period of 12 weeks helped to
reduce the dose of the calcium antagonist nifedipine in a statistically
significant manner. The intake of pine
bark extract decreased endothelin-1
concentrations significantly compared to placebo while concentrations of
6-keto prostaglandin F1a in plasma were significantly higher compared to
placebo. Values for nitric oxide (NO) in plasma increased in both groups,
but the differences were not significant. Angiotensin II concentrations in
plasma were lowered in the placebo group to a larger extent than in the pine bark extract group. Heart rate, electrolytes and blood urea
nitrogen were not changed during treatment in both groups of patients.
Unwanted effects observed in both groups were of mild and transient
nature, such as gastrointestinal problems, vertigo, headache and nausea.
Impotence or erectile dysfunction
BJU Int. 2010. Investigation of a complex plant extract for mild to moderate
erectile dysfunction in a randomized, double-blind, placebo-controlled,
parallel-arm study. Vascular Laboratories and Physiology, Department of
Biomedical Sciences, Gabriele D'Annunzio University, Chieti-Pescara, Italy.
To assess the effects of a complex plant extract (Prelox a formulation of
pine bark extract and l-arginine aspartate; Horphag Research UK Ltd, London, UK)
on erectile dysfunction (ED) in men, as sexual desire typically persists in
ageing men, while their erectile and endothelial function gradually declines. In
this double-blind, placebo-controlled study we assessed the effects of Prelox in
124 patients (aged 30-50 years) with moderate ED over an investigational period
of 6 months. Our study shows that Prelox is effective for improving erectile
function, and that this effect persists on continuous therapy for up to 6
months. Moreover, there is some evidence that erectile function continues to
improve the longer the therapy is used.
Side effects, is it safe?
Could blood thinning be a potential adverse effect?
Pine bark extract research
study
Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after
ingestion of French maritime pine bark extract (Pycnogenol).
Biomed Pharmacother. 2005.
There is evidence from several studies that supplementation with French
maritime pine bark extract improves inflammatory
symptoms in vivo. However, the molecular pharmacological basis for the
observed effects has not been fully uncovered yet. Direct inhibitory
effects of plant extracts or components upon cyclooxygenase (COX) activity
have been repeatedly reported, but the question remained whether
sufficiently high in vivo concentrations of bioactive compounds could be
achieved in humans. The purpose of the present study was to determine a
possible inhibition of the enzymatic activity of COX-1 and COX-2 by serum
samples of human volunteers after intake of French maritime pine bark
extract. This methodology considered that the serum samples would contain
any bioavailable active principle. Therefore, we obtained blood samples
before and after 5 days administration of 200 mg pine bark extract to five
healthy humans. The plasma moderately inhibited both COX-1 and COX-2
activities ex vivo. In a second approach, 10 volunteers received a single
dose of 300 mg pine bark extract. Only 30 min after ingestion of the pine
bark extract the serum samples induced a statistically significant
increase in the inhibition of both COX-1 and COX-2. This suggests a
strikingly rapid bioavailability of bioeffective compounds after oral
intake of the extract. Thus, we provide evidence that pine bark extract
exerts effects by inhibition of eicosanoid generating enzymes which is
consistent with reported clinical anti-inflammatory and platelet
inhibitory effects in vivo. The next challenge is to identify the active
principle(s) that are rapidly bioavailable in human plasma.
Inhibitory effect of pine extract on alpha-glucosidase
activity and postprandial hyperglycemia.
Nutrition. 2005.
This study investigated the inhibitory effect of pine bark extract and
needle extract on carbohydrate-hydrolyzing enzymes and the hypoglycemic
effect in diabetic mice. Pine bark and needle were dried and then
placed in ethanol, and the extracts were assayed for the measurement of
inhibition mode of pine bark extract against alpha-amylase
and alpha-glucosidase. We also investigated the effect of
long-term treatment with extracts on levels of postprandial blood glucose,
body weight, food efficiency ratio, and gene expression of glucose
transporter-4 in quadriceps muscle in diabetic mice. The pine
bark extract showed competitive inhibition against salivary alpha-amylase
and the combination of non-competitive and uncompetitive inhibition
against yeast alpha-glucosidase. Pine bark extract can be used to suppress
postprandial hyperglycemia of diabetic patients. It also can be applied
for control of obesity by decreasing the food efficiency ratio, especially
carbohydrates.
See also pine nut oil supplement information.